Literature DB >> 12378958

Preparation and characterization of heparin-loaded polymeric microparticles.

Y Y Jiao1, N Ubrich, V Hoffart, M Marchand-Arvier, C Vigneron, M Hoffman, P Maincent.   

Abstract

Microparticles containing heparin were prepared by a water-in-oil-in-water emulsification and evaporation process with pure or blends of biodegradable (poly-epsilon-caprolactone and poly(D,L-lactic-co-glycolic acid)) and of positively-charged non-biodegradable (Eudragit RS and RL) polymers. The influence of polymers and some excipients (gelatin A and B, NaCl) on the particle size, the morphology, the heparin encapsulation rate as well as the in vitro drug release was investigated. The diameter of the microparticles prepared with the various polymers ranged from 80 to 130 microns and was found to increase significantly with the addition of gelatin A into the internal aqueous phase. Microparticles prepared with Eudragit RS and RL exhibited higher drug entrapment efficiency (49 and 80% respectively) but lower drug release within 24 h (17 and 3.5% respectively) than those prepared with PCL and PLAGA. The use of blends of two polymers in the organic phase was found to modify the drug entrapment as well as the heparin release kinetics compared with microparticles prepared with a single polymer. In addition, microparticles prepared with gelatin A showed higher entrapment efficiency, but a significant initial burst effect was observed during the heparin release. The in vitro biological activity of heparin released from the formulations affording a suitable drug release has been tested by measuring the anti-Xa activity by a colorimetric assay with a chromogenic substrate. The results confirmed that heparin remained unaltered after the entrapment process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378958     DOI: 10.1081/ddc-120014740

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  9 in total

1.  Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering.

Authors:  S Teixeira; L Yang; P J Dijkstra; M P Ferraz; F J Monteiro
Journal:  J Mater Sci Mater Med       Date:  2010-07-02       Impact factor: 3.896

2.  Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.

Authors:  Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  Drug Dev Res       Date:  2006-02       Impact factor: 4.360

3.  Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique.

Authors:  Sabyasachi Maiti; Paramita Dey; Santanu Kaity; Somasree Ray; Sushomasri Maji; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2009-05-29       Impact factor: 3.246

4.  Oral delivery of low molecular weight heparin by polyaminomethacrylate coacervates.

Authors:  Angela Viehof; Alf Lamprecht
Journal:  Pharm Res       Date:  2013-05-07       Impact factor: 4.200

5.  Controlled release of liraglutide using thermogelling polymers in treatment of diabetes.

Authors:  Yipei Chen; Yuzhuo Li; Wenjia Shen; Kun Li; Lin Yu; Qinghua Chen; Jiandong Ding
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

6.  Polymeric Microsphere Formulation for Colon Targeted Delivery of 5-Fluorouracil Using Biocompatible Natural Gum Katira.

Authors:  Saumen Karan; Hira Choudhury; Biplab Kumar Chakra; Tapan Kumar Chatterjee
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

7.  Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres.

Authors:  Nusrat Motlekar; Bi-Botti Youan
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

8.  Development of enoxaparin sodium polymeric microparticles for colon-specific delivery.

Authors:  Dana Hales; Maxime Casteran; Anne Sapin-Minet; Ioan Tomuţa; Marcela Achim; Laurian Vlase; Philippe Maincent
Journal:  Clujul Med       Date:  2015-07-01

Review 9.  Strategies to Overcome Heparins' Low Oral Bioavailability.

Authors:  Ana Rita Neves; Marta Correia-da-Silva; Emília Sousa; Madalena Pinto
Journal:  Pharmaceuticals (Basel)       Date:  2016-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.